BioInvent
is a Sweden-based biotechnology company that researches and develops antibody drugs for the treatment of cancer... Read moreBioInvent
is a Sweden-based biotechnology company that researches and develops antibody drugs for the treatment of cancer... Read more
News
May 20, 2026
FinanzNachrichten
BioInvent: BioInvent International: BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026
May 12, 2026
FinanzNachrichten
BioInvent: BioInvent International: BioInvent to Present Clinical Data on FcyRIIB Antibody BI-1206 Triplet Combination Therapy with rituximab and Calquence in Relapsed/Refractory NHL at EHA 2026
May 12, 2026
FinanzNachrichten
BioInvent: BioInvent International: BioInvent's TNFR2 Antibody BI-1808 Shows Strong Activity and Immune Activation as Single Agent and in Combination with KEYTRUDA in Advanced CTCL
Apr 29, 2026
FinanzNachrichten
BioInvent: BioInvent International AB: Interim Report January - March 2026
Apr 29, 2026
FinanzNachrichten
BioInvent: BioInvent International: BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio
Apr 29, 2026
FinanzNachrichten
BioInvent: BioInvent International: Resolutions at BioInvent's Annual General Meeting 2026
Apr 21, 2026
FinanzNachrichten
BioInvent: BioInvent International: BioInvent to Present Data of BI-1808 Plus KEYTRUDA in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting
Mar 31, 2026
FinanzNachrichten
BioInvent: BioInvent International AB Publishes Annual Report 2025
Mar 26, 2026
FinanzNachrichten
BioInvent: BioInvent International: BioInvent Achieves Phase 3 Milestone for HMI-115 in Endometriosis
Feb 26, 2026
FinanzNachrichten
BioInvent: BioInvent International: Invitation to Presentation of BioInvent's Year-End Report 2025
BioInvent Competitors
1
2
3
4
5
6
7
8
9
10